Stock listing

NASDAQ:EPZM Epizyme Inc Stock

Follow Epizyme Inc into a list and get an email when it puts out news.

Last close · NASDAQ:EPZM

$1.47 USD

Close on Aug 12, 2022 · No longer trades

May 31, 2013 to last close -93.6% · weekly closes, May 31, 2013 – Aug 12, 2022
Lowest – highest close
$0.415 – $43.60 USDSince May 31, 2013 · lowest Jun 1, 2022 · highest Jul 16, 2013

Delisted NASDAQ:EPZM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:EPZM
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Epizyme Inc on 6ix

Calls
6 calls with a replay · 6 with a transcript · latest May 10, 2022
Decks
3 decks · latest Jan 4, 2019

Events

CallWhenStatus
Epizyme (EPZM) Q1 2022 Earnings CallTue, May 10, 2022 · 8:30 AM ETReplay
Epizyme (EPZM) Q4 2021 Earnings CallTue, Mar 01, 2022 · 8:30 AM ETReplay
Epizyme (EPZM) Q3 2021 Earnings CallTue, Nov 09, 2021 · 8:30 AM ETReplay
Epizyme (EPZM) Q2 2021 Earnings CallMon, Aug 09, 2021 · 8:30 AM ETReplay
Epizyme (EPZM) Q1 2021 Earnings CallThu, May 06, 2021 · 7:30 AM ETReplay
Epizyme (EPZM) Q4 2020 Earnings CallTue, Feb 23, 2021 · 8:00 AM ETReplay

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2019)Investor deck31 slidesJan 4, 2019
J.P. Morgan 2018 Healthcare ConferenceConference26 slidesJan 8, 2018
J.P. Morgan 2017 Healthcare ConferenceConference31 slidesJan 9, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Beth C Seidenberg
Other companies: Latigo Biotherapeutics, Inc. (Director · Since at least Aug 6, 2026); Kyverna Therapeutics, Inc. (Director · Since at least Feb 7, 2024); Sagimet Biosciences Inc. - Series A (Director · Since at least Jul 13, 2023); Vera Therapeutics, Inc. (Director · Since at least May 13, 2021); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Progyny, Inc. (Director · Oct 24, 2019 – May 23, 2024 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); Atara Biotherapeutics, Inc. (Director · Oct 15, 2014 – May 31, 2023 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past)
Director · May 30, 2013 – Jun 30, 2019 · Past
Jason Rhodes
Other companies: Dyne Therapeutics, Inc. (Chairman · Since at least Sep 16, 2020); Generation Bio Co (Director · Since at least Jun 11, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Replimune Group, Inc. (Director · Jul 19, 2018 – Apr 1, 2022 · Past)
President, CFO and Treasurer · May 30, 2013 – Sep 22, 2014 · Past
Richard F. Pops
Other companies: Alkermes plc (Director · Since at least Sep 10, 2015); Neurocrine Biosciences, Inc. (Director · Since at least May 28, 2015); Acceleron Pharma Inc (Director · Mar 3, 2016 – Jan 25, 2019 · Past)
Director · Jul 8, 2015 – May 29, 2020 · Past
Matthew Ros
Other companies: Cogent Biosciences, Inc. (Pharma-Biotech Executive · Since at least Jul 26, 2019); Verastem, Inc. (Chief Operating Officer · Jan 14, 2025 – Nov 4, 2026 · Past)
See Remarks · May 16, 2016 – Aug 16, 2021 · Past
Susan E. Graf
Other companies: Aardvark Therapeutics, Inc. (Board Member · Since at least Feb 12, 2025); CG Oncology, Inc. (Director · Since at least Jan 24, 2024)
Chief Business Officer · Apr 25, 2016 – Feb 9, 2018 · Past
Carol Stuckley
Other companies: Centessa Pharmaceuticals PLC (Director · Since at least May 27, 2021)
Director · Nov 16, 2021 – Aug 12, 2022 · Past
Joseph Beaulieu
Other companies: Disc Medicine, Inc. (SVP, Finance · Since at least Nov 5, 2026)
See Remarks · Aug 9, 2022 – Aug 12, 2022 · Past
Michael F Giordano
Other companies: RAPT Therapeutics Inc (Director · Since at least May 28, 2021)
Director · Jun 11, 2021 – Aug 12, 2022 · Past
Roy A Beveridge
Other companies: Humana Inc. (Chief Medical Officer · Jun 17, 2013 – Apr 1, 2019 · Past)
Director · Nov 16, 2021 – Aug 12, 2022 · Past
Andrew E SingerEVP & CFO · Feb 8, 2016 – Aug 9, 2017 · Past
All 11 people
PersonSeat
Suzanne FlemingSVP · Sep 20, 2017 – Feb 9, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Epizyme Inc.